Travere Therapeutics, Inc.
Net SellingTVTX·US·🇺🇸 US
0%buys·100%sells
7 transactions$0Total buys·0 buys
$2.2MTotal sells·3 sells
22 insiders
Last: Apr 1, 2026
| Date | Insider | Type | Value | |
|---|---|---|---|---|
| Apr 15, 26 | Cline Christopher R. | Sell | $43K | |
| Apr 15, 26 | Inrig Jula | Sell | $43K | |
| Apr 15, 26 | Dube Eric M | Sell | $853 | |
| Apr 15, 26 | Dube Eric M | Sell | $299K | |
| Apr 15, 26 | Dube Eric M | Sell | $2.3M | |
| Apr 15, 26 | REED ELIZABETH E | Sell | $66K | |
| Apr 15, 26 | REED ELIZABETH E | Sell | $218K | |
| Apr 14, 26 | Cline Christopher R. | Sell | $304K | |
| Apr 14, 26 | Cline Christopher R. | Sell | $370 | |
| Apr 14, 26 | Inrig Jula | Sell | $303K |
Travere Therapeutics, Inc. is seeing coordinated insider selling. 4 insiders sold shares in the last 30 days, with total sell volume of $3.6M. Overall insider sentiment is bearish (100% sales).
Travere Therapeutics, Inc. (TVTX) has recorded 7 insider operations, including 0 open-market purchases ($0), 3 sales ($2.2M) and 4 other operations (stock option exercises, grants, tax dispositions, donations). The insider sentiment is bearish (100% sales).
Recent activity is concentrated over 1 months in the last year.
Among the most active insiders are Dube Eric M (CEO) & REED ELIZABETH E (C SUITE), with respectively 71, 119 transactions.
Across all 36 recorded transactions, the breakdown by type is: sells (18, 50%), exercise (12, 33%), grant (6, 17%).
Data sourced from regulatory filings (SEC Form 4, AMF, BaFin, FI, and other European authorities).
Travere Therapeutics, Inc. has recorded 7 insider operations in total, including 0 open-market purchases ($0), 3 sales ($2.2M) and 4 other operations (stock option exercises, grants, tax dispositions, donations). The most recent transaction was recorded on April 1, 2026.
Insiders at Travere Therapeutics, Inc. are currently net sellers, with 0% purchases and 100% sales across all reported transactions. Total buy volume is $0 versus $2.2M in sales, indicating a bearish insider sentiment.
InsiderLens tracks 2 insiders at Travere Therapeutics, Inc. (TVTX). Dube Eric M (CEO, 71 tx), REED ELIZABETH E (C SUITE, 119 tx). Data is sourced from mandatory regulatory filings for persons with access to privileged information.
The insider signal for TVTX is bearish, based on a 0% buy ratio across 3 buy and sell transactions reported to financial regulators. Transactions from C-suite executives (CEO, CFO) and board members are generally considered the most informative signals.
Insider trading data for Travere Therapeutics, Inc. comes from official regulatory filings: SEC Form 4 (United States), AMF (France), BaFin (Germany), FI (Sweden), and other European financial authorities. These filings are mandatory for directors, officers, and holders of more than 10% of a company's shares. InsiderLens aggregates and normalizes this data for analysis.